Cargando…
Organoid technology in disease modelling, drug development, personalized treatment and regeneration medicine
Organoid technology bridges the gap between conventional two-dimensional cell line culture and in vivo models. The near-physiological technology can virtually recapitulates organ development and human diseases, such as infectious diseases, genetic abnormality and even cancers. In addition, organoids...
Autores principales: | Xu, Hanxiao, Jiao, Ying, Qin, Shuang, Zhao, Weiheng, Chu, Qian, Wu, Kongming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282260/ https://www.ncbi.nlm.nih.gov/pubmed/30534474 http://dx.doi.org/10.1186/s40164-018-0122-9 |
Ejemplares similares
-
Organoid technology and applications in cancer research
por: Xu, Hanxiao, et al.
Publicado: (2018) -
Tumor organoids: applications in cancer modeling and potentials in precision medicine
por: Xu, Hanxiao, et al.
Publicado: (2022) -
Gut microbiome modulates efficacy of immune checkpoint inhibitors
por: Yi, Ming, et al.
Publicado: (2018) -
EYA2 Correlates With Clinico-Pathological Features of Breast Cancer, Promotes Tumor Proliferation, and Predicts Poor Survival
por: Xu, Hanxiao, et al.
Publicado: (2019) -
Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors
por: Yi, Ming, et al.
Publicado: (2018)